TB-antigens, recombinant, purified
Recombinant produced antigen from Mycobacterium tuberculosis is available from Statens Serum Institut.
Application
The typical application is research on TB infections. The antigen is not present in BCG strains and therefore will not stimulate samples from BCG vaccinated individuals.
The antigen is for laboratory research purpose only and for in vitro use only.
Matrial Transfer Agreement (MTA)
Prior to purchase of the recombinat antigen you are required to fill in a Material Transfer Agreement (MTA), as several Intellectual Property Rights (IPR) worldwide covers the products.
Product information
See rdESAT6, recombinant, purified
Last revised 24 November 2011